Table 4.
2010 | 2011 | 2012 | 2013 | 2014 | P | |
---|---|---|---|---|---|---|
In-hospital outcome | (n = 804) | (n = 930) | (n = 1045) | (n = 1241) | (n = 1268) | |
Death (%) | 15 (1.8) | 10 (1.1) | 3 (0.3) | 2 (0.2) | 7 (0.6) | 0.000 |
Complications (%) | ||||||
Cardiogenic shock | 17 (2.1) | 19 (2.0) | 4 (0.4) | 8 (0.6) | 5 (0.4) | 0.000 |
Major bleeding | 8 (1.0) | 7 (0.8) | 12 (1.1) | 10 (0.8) | 12 (0.9) | NS |
AV block | 2 (0.2) | 1 (0.1) | 2 (0.2) | 3 (0.2) | - | NS |
VT and/or VF | 22 (2.7) | 25 (2.7) | 22 (21.1) | 21 (16.9) | 23 (18.1) | NS |
Thrombosis | 2 (0.2) | 4 (0.4) | 3 (0.3) | 7 (0.6) | 7 (0.6) | NS |
Out-hospital outcome | N = 738 | N = 840 | N = 1017 | N = 1216 | N = 1257 | |
MACE (%) | 18 (2.4) | 18 (2.1) | 22 (2.2) | 17 (1.4) | 20 (1.6) | NS |
Cardiac death | 1 (0.1) | - | 1 (0.1) | 3 (0.2) | 1 (0.1) | NS |
MI | 10 (1.3) | 14 (1.7) | 14 (1.4) | 13 (1.1) | 16 (1.3) | NS |
Re-PCI | 17 (2.3) | 18 (2.1) | 22 (2.2) | 17 (1.4) | 19 (1.5) | NS |
CABG | 1 (0.1) | - | - | - | 1 (0.1) | NS |
Stroke | - | - | - | 1 | - | NS |
Abbreviations: VT ventricular tachycardia, VF ventricular fibrillation, MACE major adverse cardiac event, PCI percutaneous coronary intervention, TVR target vessel revascularization, TLR target lesion revascularization, MI myocardial infarction, CABG coronary artery bypass graft